Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neuroprotective heterocyclic compounds developed at Cambridge NeuroScience

May 19, 1998

Rivastigmine ameliorates immediate and long-term sequelae of closed-head injury

May 19, 1998

Postmarketing evaluation of Clozaril may lead to increased patient availability

May 19, 1998

Scios and Janssen to copromote Risperdal

May 18, 1998

European Commission approves Novartis' Exelon

May 18, 1998

Ondansetron suppresses spontaneous sleep apnea in rats

May 18, 1998

Novel isoquinolines prepared at Snow Brand Milk Products inhibit neuronal cell death

May 15, 1998

TheraTech and Astra announce collaborative development of new pain medication

May 14, 1998

Pharmacokinetic profile of GTS-21 studied in rats after parenteral, oral dosing

May 14, 1998

Myotrophin declared "potentially approvable" by FDA

May 14, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...